Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research

Stage IIIA non-small-cell lung carcinoma (NSCLC) is composed of regionally advanced yet potentially resectable disease. Many trials have evaluated a variety of therapeutic strategies. Most have been single-arm phase II trials, although a number of comparative phase III trials have also been performe...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical oncology 1992-05, Vol.10 (5), p.829-838
Hauptverfasser:	STRAUSS, G. M, LANGER, M. P, ELIAS, A. D, SKARIN, A. T, SUGARBAKER, D. J
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - therapy Chemotherapy Chemotherapy, Adjuvant Combined Modality Therapy Drug Evaluation Humans Lung Neoplasms - pathology Lung Neoplasms - therapy Medical sciences Neoplasm Staging Pharmacology. Drug treatments Randomized Controlled Trials as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!